Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| DNA Script | 2025 | Grant | Undisclosed | Le Kremlin-bicêtre |
| COMPASS Pathways | 2026 | Post-IPO Equity | Undisclosed | Altrincham |
| Cambrian Biopharma | 2026 | Grant | Undisclosed | New York |
| ProSomnus Sleep Technologies | 2026 | Venture - Series Unknown | Undisclosed | Pleasanton |
| Somethings | 2026 | Series A | Undisclosed | New York |
| Star Therapeutics | 2025 | Series D | $125.0M | South San Francisco |
| Leo Cancer Care | 2025 | Venture - Series Unknown | $40.0M | Harley |
| Ensoma | 2025 | Venture - Series Unknown | $53.0M | Boston |
| Character Biosciences | 2025 | Series B | $17.0M | Jersey City |
| Enveda Biosciences | 2025 | Series D | $150.0M | Boulder |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | DNA Script | Grant | Undisclosed | Le Kremlin-bicêtre, France |
| 27 | COMPASS Pathways | Post-IPO Equity | Undisclosed | Altrincham, United Kingdom |
| 28 | Cambrian Biopharma | Grant | Undisclosed | New York, United States |
| 29 | ProSomnus Sleep Technologies | Venture - Series Unknown | Undisclosed | Pleasanton, United States |
| 30 | Somethings | Series A | Undisclosed | New York, United States |
| 31 | Star Therapeutics | Series D | $125.0M | South San Francisco, United States |
| 32 | Leo Cancer Care | Venture - Series Unknown | $40.0M | Harley, United Kingdom |
| 33 | Ensoma | Venture - Series Unknown | $53.0M | Boston, United States |
| 34 | Character Biosciences | Series B | $17.0M | Jersey City, United States |
| 35 | Enveda Biosciences | Series D | $150.0M | Boulder, United States |
DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Cambrian is a distributed development company building therapeutics to lengthen health span.
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Leo Cancer Care constantly seeking to optimise and improve.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
OSPRI is updating the infectious illness testing plan.
Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Roshal Imaging Services is a provider of on-site and portable diagnostic Vascular and General body (OB/Gyn) ultrasound services.
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Catalio Capital Management has invested in 110 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 24 different industry categories.
Among tracked funding rounds, Enveda Biosciences received $150.0M in a Series D round. Catalio Capital Management's total known invested capital is $5.2B.
Catalio Capital Management's average investment size is $72.8M across its portfolio of 110 companies.
Recent Catalio Capital Management portfolio additions include DNA Script, COMPASS Pathways, Cambrian Biopharma, ProSomnus Sleep Technologies, Somethings. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors